| Diabetes Treatment and Management | Lifetime | 29 | DE 2 | 99.83 |
| Dialysis and Renal Disease Management | Lifetime | 21 | DE 1 | 99.81 |
| Lysosomal Storage Disorders Research | Lifetime | 12 | DE 3 | 99.59 |
| Chronic Kidney Disease and Diabetes | Lifetime | 20 | DE 1 | 99.79 |
| Neurological and metabolic disorders | Lifetime | 10 | DE 2 | 99.64 |
| Lipoproteins and Cardiovascular Health | Lifetime | 75 | DE 4 | 99.55 |
| Pancreatic function and diabetes | Lifetime | 153 | DE 5 | 99.40 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 42 | DE 3 | 98.71 |
| Diabetes Management and Research | Lifetime | 272 | DE 12 | 98.94 |
| Muscle and Compartmental Disorders | Lifetime | 73 | DE 1 | 98.27 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 350 | DE 11 | 98.73 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 734 | DE 15 | 98.34 |
| Potassium and Related Disorders | Lifetime | 84 | DE 4 | 98.06 |
| Trypanosoma species research and implications | Lifetime | 253 | DE 9 | 97.99 |
| Renal Diseases and Glomerulopathies | Lifetime | 461 | DE 29 | 97.81 |
| Erythropoietin and Anemia Treatment | Lifetime | 151 | DE 16 | 97.36 |
| Blood Pressure and Hypertension Studies | Lifetime | 896 | DE 26 | 97.63 |
| Acute Kidney Injury Research | Lifetime | 318 | DE 17 | 96.77 |
| Biomedical Research and Pathophysiology | Lifetime | 135 | DE 17 | 96.48 |
| Metabolism, Diabetes, and Cancer | Lifetime | 866 | DE 48 | 97.11 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 836 | DE 54 | 95.26 |
| Studies on Chitinases and Chitosanases | Lifetime | 325 | DE 11 | 90.84 |
| Pharmacology and Obesity Treatment | Lifetime | 950 | DE 49 | 91.01 |
| Dialysis and Renal Disease Management | 2021-2025 | 9 | DE 1 | 99.63 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 9 | DE 1 | 99.70 |
| Diabetes Treatment and Management | 2021-2025 | 25 | DE 1 | 99.74 |
| Pancreatic function and diabetes | 2021-2025 | 37 | DE 1 | 98.99 |
| Diabetes Management and Research | 2021-2025 | 181 | DE 10 | 97.44 |
| Lysosomal Storage Disorders Research | 2021-2025 | 64 | DE 9 | 95.80 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 151 | DE 13 | 94.82 |
| Hormonal Regulation and Hypertension | 2021-2025 | 174 | DE 21 | 93.68 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 58 | DE 6 | 93.31 |
| Potassium and Related Disorders | 2021-2025 | 74 | DE 3 | 93.73 |
| Electrolyte and hormonal disorders | 2021-2025 | 194 | DE 10 | 85.13 |
| Trypanosoma species research and implications | 2021-2025 | 420 | DE 12 | 85.93 |
| Renal function and acid-base balance | 2021-2025 | 178 | DE 5 | 79.13 |
| Muscle and Compartmental Disorders | 2021-2025 | 175 | DE 12 | 77.64 |
| Acute Kidney Injury Research | 2021-2025 | 674 | DE 24 | 80.33 |
| Pharmacology and Obesity Treatment | 2021-2025 | 372 | DE 17 | 76.48 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 245 | DE 14 | 74.20 |
| Neurological and metabolic disorders | 2021-2025 | 193 | DE 7 | 72.46 |
| Apelin-related biomedical research | 2021-2025 | 636 | DE 20 | 39.40 |
| Biomedical Research and Pathophysiology | 2021-2025 | 751 | DE 61 | 36.13 |
